Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020

Kilic, Betul; SERDAROĞLU, ESRA; Polat, Burcin; Ince, Tugce; ESENÜLKÜ, GÜLNUR; Topcu, Yasemin; SERDAROĞLU, AYŞE; HASPOLAT, ŞENAY; TEKGÜL, HASAN; OKUYAZ, ÇETİN; CANSU, ALİ; Aydin, Kursad

doi:10.1016/j.seizure.2022.05.005

Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020

Kilic B., SERDAROĞLU E., Polat B. G., Ince T., ESENÜLKÜ G., Topcu Y., ...Daha Fazla

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, cilt.99, ss.48-53, 2022 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 99
Basım Tarihi: 2022
Doi Numarası: 10.1016/j.seizure.2022.05.005
Dergi Adı: SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Psycinfo
Sayfa Sayıları: ss.48-53
Anahtar Kelimeler: juvenile myoclonic epilepsy, valproic acid, levetiracetam, LEVETIRACETAM, VALPROATE, MONOTHERAPY, MANAGEMENT
Gazi Üniversitesi Adresli: Evet

Özet

Purpose:Valproic acid (VPA) is frequently used and effective in juvenile myoclonic epilepsy (JME). Recently, levetiracetam (LEV) has been suggested as a monotherapy in JME. This study aimed to evaluate antiseizure medication (ASM) use in patients with JME.